One month of blood thinners after heart bypass surgery
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether taking just one month of two blood thinners after coronary artery bypass graft (CABG) surgery is safe and as effective as the standard longer course. It focuses on people having their first bypass surgery who receive at least one vein graft from the leg.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are scheduled for your first heart bypass surgery and will receive at least one vein graft from your leg
- You are willing to sign a consent form and commit to follow-up visits for at least 5 years
- You do NOT have other heart procedures planned at the same time
- You do NOT have any active bleeding or bleeding disorders
- You do NOT use blood thinners other than aspirin or ticagrelor
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different lengths of time for taking a blood thinner after heart bypass surgery to see which is safer and works better. It may help reduce the risk of blood clots or bleeding after surgery.
This study follows patients who had a first-time heart bypass operation (CABG) to see how a blood-thinning medicine called ticagrelor affects their recovery and long-term health. It may help doctors understand the best way to prevent complications after surgery.
This Phase 3 trial compares two strategies to prevent blood clots after heart bypass surgery: aspirin alone versus aspirin plus ticagrelor. It aims to see which approach works better and is safer for people whose bypass does not fully restore blood flow.
This trial studies which blood-thinning medicine combination is safest and most helpful after coronary bypass surgery combined with a procedure to unblock the artery (endarterectomy). It focuses on preventing dangerous blood clots while also avoiding excess bleeding.
This trial tests whether using a blood thinner in people with new, temporary atrial fibrillation after CABG (heart bypass surgery) can reduce harmful outcomes compared with standard treatment. It may help prevent stroke or other complications if your rhythm problem fits the trial’s timing and risk profile.
This trial tests if people who have been on two blood thinners (aspirin plus prasugrel or ticagrelor) for at least 90 days after getting a heart stent can safely switch to just one of those blood thinners. It aims to see if taking only one pill is as safe and effective as taking two.
Hear when a new Chronic Coronary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.